These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1008991)

  • 81. Testosterone and breast cancer prevention.
    Glaser R; Dimitrakakis C
    Maturitas; 2015 Nov; 82(3):291-5. PubMed ID: 26160683
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Total lymphocyte-counts in breast cancer.
    Bainbridge ET; Ford CH; Newman CE
    Lancet; 1978 Jun; 1(8075):1203-4. PubMed ID: 77967
    [No Abstract]   [Full Text] [Related]  

  • 83. Fragilitas ossium hereditaria with blue sclerae and its treatment with androgens and oestrogens.
    HERNBERG CA
    Acta Med Scand; 1952 Feb; 141(5):309-16. PubMed ID: 14923255
    [No Abstract]   [Full Text] [Related]  

  • 84. Total lymphocyte-counts in breast cancer.
    Stell PM
    Lancet; 1978 Jul; 2(8081):158. PubMed ID: 78360
    [No Abstract]   [Full Text] [Related]  

  • 85. Assessing individual risk for breast cancer: role of oestrogens and androgens.
    Santen RJ
    Breast Cancer Res; 2008; 10 Suppl 4(Suppl 4):S10. PubMed ID: 19128423
    [No Abstract]   [Full Text] [Related]  

  • 86. The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of 105 female patients.
    ADAIR FE; MELLORS RC
    J Am Med Assoc; 1949 Aug; 140(15):1193-1200. PubMed ID: 18136181
    [No Abstract]   [Full Text] [Related]  

  • 87. [Combined hormone and cytostatic therapy of advanced mammary carcinoma].
    Di Pietro S; Salvadori B
    Tumori; 1966; 52(1):17-28. PubMed ID: 5916459
    [No Abstract]   [Full Text] [Related]  

  • 88. Effect of operation on peripheral lymphocyte counts and production of adenosine triphosphate (ATP) in cancer patients.
    Mukherjee M; Sahasrabuddhe MB
    J Surg Oncol; 1982 May; 20(1):1-8. PubMed ID: 7078179
    [TBL] [Abstract][Full Text] [Related]  

  • 89. T and B lymphocytes in breast cancer.
    Teasdale C; Thatcher J; Whitehead RH; Chare MJ; Hughes LE
    Lancet; 1977 Mar; 1(8010):543-4. PubMed ID: 65635
    [No Abstract]   [Full Text] [Related]  

  • 90. The effect of stanolone in the treatment of advanced breast cancer.
    KENNEDY BJ
    Cancer; 1955; 8(3):488-97. PubMed ID: 14379136
    [No Abstract]   [Full Text] [Related]  

  • 91. Hormone-treated primary operable breast carcinoma; a pathological study of 33 cases.
    GODWIN JT; ESCHER GC
    Cancer; 1951 Jan; 4(1):136-40. PubMed ID: 14801780
    [No Abstract]   [Full Text] [Related]  

  • 92. [Ovarial changes in hormone therapy of breast carcinoma].
    ELSNER P; TISCHER H
    Arch Gynakol; 1952 May; 181(4):462-76. PubMed ID: 14953309
    [No Abstract]   [Full Text] [Related]  

  • 93. Histological and histochemical alterations in the normal breast tissues of patients with advanced breast cancer being treated with estrogenic hormones.
    HUSEBY RA; THOMAS LB
    Cancer; 1954 Jan; 7(1):54-74. PubMed ID: 13126901
    [No Abstract]   [Full Text] [Related]  

  • 94. [Osteoplastic reaction of unusual measure following hormone treatment of bone metastasis from breast cancer].
    GODAN F
    Magy Radiol; 1952 Nov; 4(4):183. PubMed ID: 13036287
    [No Abstract]   [Full Text] [Related]  

  • 95. Effect of endogenous androgens on lymphocyte subpopulations.
    Dunkel L; Taino VM; Savilahti E; Eskola J
    Lancet; 1985 Aug; 2(8452):440-1. PubMed ID: 2863460
    [No Abstract]   [Full Text] [Related]  

  • 96. IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?
    Deschoemaeker S; Laoui D
    EBioMedicine; 2020 Mar; 53():102690. PubMed ID: 32109837
    [No Abstract]   [Full Text] [Related]  

  • 97. Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib.
    Emile G; Penager S; Levy C; Johnson A; Allouache D; Lequesne J; Hrab I; Segura C; Morel A; Gunzer K; Faveyrial A; Cherifi F; Da Silva A
    Oncol Lett; 2022 Jan; 23(1):25. PubMed ID: 34868362
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Endocrine function and immunity.
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):88-9. PubMed ID: 6789947
    [No Abstract]   [Full Text] [Related]  

  • 99. Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis.
    Lee YT; Sheikh KM; Quismorio FP; Friou GJ
    Breast Cancer Res Treat; 1985; 6(1):57-65. PubMed ID: 3902126
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
    Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
    Cancer Immunol Immunother; 1986; 21(1):6-11. PubMed ID: 3632917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.